Corbus director sells 4,800 shares under 10b5-1 plan
Corbus Pharmaceuticals Holdings, Inc. director John Kenneth Jenkins reported an open-market sale of 4,800 shares of common stock on June 10, 2026 at a weighted average price of $7.9137 per share, executed under a Rule 10b5-1 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Corbus Pharmaceuticals Holdings, Inc. director John Kenneth Jenkins reported an open-market sale of 4,800 shares of common stock on June 10, 2026 at a weighted average price of $7.9137 per share, executed under a Rule 10b5-1 trading plan. Following this sale, he directly holds 3,833 shares of common stock and 3,800 unvested RSUs subject to the grant’s vesting schedule.
Insider Trade Summary 10b5-1
Net Seller: 4,800 shares
Net Sell
1 txn
Insider
Jenkins John Kenneth
Role
Director
Sold
4,800 shs ($38K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $0.0001 per share | 4,800 | $7.9137 | $38K |
Holdings After Transaction:
Common Stock, par value $0.0001 per share — 3,833 shares (Direct)
Footnotes (3)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.
- F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. This amount includes 3,800 unvested RSUs subject to the grant's vesting schedule as previously reported.
Key Figures
Shares sold: 4,800 shares
Weighted average sale price: $7.9137 per share
Price range of trades: $7.71–$7.97 per share
+2 more
5 metrics
Shares sold
4,800 shares
Open-market sale on June 10, 2026
Weighted average sale price
$7.9137 per share
Common stock sale on June 10, 2026
Price range of trades
$7.71–$7.97 per share
Multiple transactions underlying weighted average price
Shares held after transaction
3,833 shares
Direct common stock ownership following sale
Unvested RSUs
3,800 units
Unvested RSUs subject to vesting schedule
Key Terms
Rule 10b5-1 trading plan, weighted average price, RSUs, open-market sale
4 terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
RSUs financial
"This amount includes 3,800 unvested RSUs subject to the grant's vesting schedule as previously reported."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Corbus Pharmaceuticals (CRBP) report for John Kenneth Jenkins?
Corbus director John Kenneth Jenkins reported selling 4,800 shares of common stock in an open-market transaction. The sale took place on June 10, 2026, and is detailed in a Form 4 insider trading report filed with the Securities and Exchange Commission.
What does the price range in John Kenneth Jenkins’ Corbus (CRBP) sale mean?
The filing explains the reported price is a weighted average, with underlying trades between $7.71 and $7.97 per share. Jenkins undertakes to provide full details on the number of shares sold at each separate price within this range upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
